Azithromycin for injection
Reason category: cGMP deviations
FDA recall number D-0997-2022
Antibiotic
Azithromycin 250 mg tablet
Public data on azithromycin from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.
$0.2708
NADAC per ea (2026-11)
approximate acquisition cost, not a retail price
-43%
change over five years
peak $0.6928 in 2018-05
62
approved generic applications (ANDAs) on record for Azithromycin
39 with a product still marketed · first 2005
Not listed
in FDA's current shortage list
Azithromycin Injection: To Be Discontinued; Azithromycin Tablet: To Be Discontinued
NADAC per unit, monthly
AZITHROMYCIN 250 MG TABLETShow as table
| Month | NADAC per unit ($) |
|---|---|
| 2013-11 | 0.50091 |
| 2014-02 | 0.60018 |
| 2014-05 | 0.45776 |
| 2014-08 | 0.56319 |
| 2014-11 | 0.54185 |
| 2015-02 | 0.51487 |
| 2015-05 | 0.52940 |
| 2015-08 | 0.51116 |
| 2015-11 | 0.41043 |
| 2016-02 | 0.50546 |
| 2016-05 | 0.42067 |
| 2016-08 | 0.47671 |
| 2016-11 | 0.36978 |
| 2017-02 | 0.53609 |
| 2017-05 | 0.55745 |
| 2017-08 | 0.50171 |
| 2017-11 | 0.54426 |
| 2018-02 | 0.57824 |
| 2018-05 | 0.69276 |
| 2018-08 | 0.67473 |
| 2018-11 | 0.61200 |
| 2019-02 | 0.53137 |
| 2019-05 | 0.53415 |
| 2019-08 | 0.53707 |
| 2019-11 | 0.58049 |
| 2020-02 | 0.60237 |
| 2020-05 | 0.58960 |
| 2020-08 | 0.58145 |
| 2020-11 | 0.54710 |
| 2021-02 | 0.56317 |
| 2021-05 | 0.51198 |
| 2021-08 | 0.53441 |
| 2021-11 | 0.47194 |
| 2022-02 | 0.49639 |
| 2022-05 | 0.42439 |
| 2022-08 | 0.36153 |
| 2022-11 | 0.36676 |
| 2023-02 | 0.33909 |
| 2023-05 | 0.33784 |
| 2023-08 | 0.34162 |
| 2023-11 | 0.33112 |
| 2024-02 | 0.35684 |
| 2024-05 | 0.38542 |
| 2024-08 | 0.37575 |
| 2024-11 | 0.32706 |
| 2025-02 | 0.34171 |
| 2025-05 | 0.36674 |
| 2025-08 | 0.37067 |
| 2025-11 | 0.34173 |
| 2026-02 | 0.29634 |
| 2026-05 | 0.28175 |
| 2026-08 | 0.26777 |
| 2026-11 | 0.27085 |
Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.
Recall records mentioning azithromycin
openFDA enforcement records, by year reported.
| 2022 | 1 |
| 2018 | 1 |
| 2016 | 2 |
| 2015 | 8 |
| 2014 | 1 |
13 records since 2012. A record is one product or lot, not one recall event. Combination products that contain azithromycin are included.
What these numbers mean
NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.
Most recent recall records
Azithromycin product
Reason category: Other
FDA recall number D-0754-2018
Azithromycin tablets
Reason category: cGMP deviations
FDA recall number D-0560-2016
Azithromycin product
Reason category: cGMP deviations
FDA recall number D-0561-2016
Azithromycin tablets
Reason category: cGMP deviations
FDA recall number D-1263-2015
Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.
Articles that mention azithromycin
5 GxRadar articles cite or discuss this drug.
Cash price & comparison · How-to guide · 6 min
How to compare pharmacy cash prices for a generic prescription
A 2014 phone survey found one generic antibiotic priced from $5 to $229 in a single county. How to compare cash quotes by phone, and how to read them against NADAC.
Price histories · Data story · 5 min
Nitrofurantoin and the antibiotic price story
Pharmacies paid $1.77 for a nitrofurantoin capsule in January 2014 and 28 cents in October 2026. How six oral antibiotics' prices diverged, why competition explains much of it, and where shortages fit.
Price histories · Data story · 5 min
The cheapest pills in GxRadar's 47-drug price basket
Seven of the 47 generics we track cost pharmacies under 2 cents a unit in October 2026, led by amlodipine at 1.02 cents. Which drugs sit at the floor, how long they have been there, and what the ranking does not show.
Shortage data · Data story · 5 min
The 'to be discontinued' entries on FDA's shortage list
FDA listed 161 drugs as to be discontinued in October 2026, more than twice its current shortages. Most are one maker's exit from one product, and discontinuations rarely start a shortage on their own.
Causes & tracking · Explainer · 6 min
Why antibiotics keep running short
Seven anti-infectives were on FDA's current shortage list in October 2026, one of them since 2015, and 30 more had discontinuation notices. Low prices and few makers explain much of it, federal research shows.